HER2 Tumor Vaccine
LWY22003CBY
Phase 1 mab active
Quick answer
HER2 Tumor Vaccine for Adenocarcinoma - GEJ is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Adenocarcinoma - GEJ
- Phase
- Phase 1
- Modality
- mab
- Status
- active